Skip to main content
Fig. 2 | Cancer Imaging

Fig. 2

From: Nomograms based on SUVmax of 18F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma

Fig. 2

Prognostic nomograms for PFS and OS. To use the nomograms, the total points for each patient are obtained by summing the points identified on the scale for each variable. The sum of the points is plotted on the “total points” axis, and then a line is drawn downward toward the risk axis labeled “3- and 5-year PFS/OS” to determine the probabilities of the outcomes for an individual patient. PFS, progression-free survival; OS, overall survival; LDH, lactate dehydrogenase; β2-MG, β2-microglobulin; Hb, hemoglobin

Back to article page
\